---
title: "WEIGUANG released its performance for the first half of the year, with a net profit attributable to the parent company of 172 million yuan, a year-on-year increase of 11.32%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253018685.md"
description: "According to the Zhitong Finance APP, WEIGUANG released its semi-annual report for 2025. During the reporting period, the company achieved operating revenue of 750 million yuan, a year-on-year increase of 10.00%. The net profit attributable to shareholders of the listed company was 172 million yuan, a year-on-year increase of 11.32%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 155 million yuan, a year-on-year increase of 2.03%. The basic earnings per share were 0.75 yuan"
datetime: "2025-08-14T10:49:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253018685.md)
  - [en](https://longbridge.com/en/news/253018685.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253018685.md)
---

# WEIGUANG released its performance for the first half of the year, with a net profit attributable to the parent company of 172 million yuan, a year-on-year increase of 11.32%

According to the Zhitong Finance APP, WEIGUANG (002801.SZ) released its semi-annual report for 2025. During the reporting period, the company achieved operating revenue of 750 million yuan, a year-on-year increase of 10.00%. The net profit attributable to shareholders of the listed company was 172 million yuan, a year-on-year increase of 11.32%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 155 million yuan, a year-on-year increase of 2.03%. The basic earnings per share were 0.75 yuan

### Related Stocks

- [002801.CN](https://longbridge.com/en/quote/002801.CN.md)

## Related News & Research

- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [Apple Flavor to Buy NovoSana’s China Assets for Up to USD66 Million in Health Supplements Push](https://longbridge.com/en/news/287039106.md)
- [Sight & Sound Theatres® to Bring Two Beloved Biblical Productions to Their Stages in 2027!](https://longbridge.com/en/news/287099784.md)
- [Iran Threatens 'Crushing Blows' Beyond The Middle East If US Resumes Attack After Trump's Near-Strike Reveal: 'In Places You Cannot Imagine…'](https://longbridge.com/en/news/287065996.md)
- [UAE urges Iraq to prevent hostile acts from its territory, after attack on nuclear plant](https://longbridge.com/en/news/287055196.md)